Amanda Ullman is a seasoned Medical Affairs Leader currently serving as the Senior Director of Scientific Strategy at Syndax Pharmaceuticals since 2025. They previously held the position of Head of Scientific Strategy and Communications in Global Medical Affairs at Adaptimmune from 2024 to 2025. Amanda's extensive experience includes roles such as Associate Director of US Medical Affairs at Bristol Myers Squibb, Medical Director of Hematology at Stemline Therapeutics, and Medical Science Liaison positions at AbbVie and Ferring Pharmaceuticals. They earned a PhD in Molecular Genetics and Microbiology from Stony Brook University and a BSc in Microbiology and Immunology with distinction from McGill University.
This person is not in any teams
This person is not in any offices